Activated prothrombin complex concentrate for reversal of oral factor Xa inhibitors at a level 1 trauma center

被引：1
|
作者：
Bobby, Lauren [1 ]
Westlake, Evan [1 ]
Esplin, Nathan [2 ]
Young, Sarah [1 ]
机构：
[1] Allegheny Gen Hosp, Dept Pharm, 320 North Ave, Pittsburgh, PA 15212 USA
[2] Allegheny Gen Hosp, Dept Neurosurg, 320 North Ave, Pittsburgh, PA 15212 USA
来源：
THROMBOSIS RESEARCH | 2021年 / 206卷
关键词：
Apixaban; Rivaroxaban; Reversal; Activated prothrombin complex concentrate (aPCC); Intracranial hemorrhage (ICH); Andexanet alfa; ANTICOAGULANTS; MANAGEMENT; OUTCOMES; FEIBA;
D O I：
10.1016/j.thromres.2021.08.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：33 / 35
页数：3
相关论文
共 50 条
  • [41] Comparison of Fixed Versus Weight-Based Prothrombin Complex Concentrate Dosing Strategies for Factor Xa Inhibitor Reversal
    Brett, Snyder
    Taylor, Miller
    Pamela, McCormick
    Michael, Gionfriddo
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2024, 30
  • [42] Real-world clinical outcomes among US Veterans with oral factor xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate
    Sutton, S. Scott
    Magagnoli, Joseph
    Cummings, Tammy H.
    Dettling, Theresa
    Lovelace, Belinda
    Christoph, Mary J.
    Hardin, James W.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 56 (01) : 137 - 146
  • [43] A Retrospective Review of Four-Factor Prothrombin Complex Concentrate for Factor Xa Inhibitor-Related Bleedings
    Hitchcock, Zachary R.
    Smith, Spencer D.
    Le, Lamanh T.
    Lees, Lauren R.
    Brandt, Matthew D.
    JOURNAL OF PHARMACY PRACTICE, 2023, 36 (02) : 221 - 226
  • [44] EVALUATION OF WARFARIN REVERSAL WITH 4-FACTOR PROTHROMBIN COMPLEX CONCENTRATE COMPARED TO 3-FACTOR PROTHROMBIN COMPLEX CONCENTRATE AT A TERTIARY ACADEMIC MEDICAL CENTER
    Al-Majzoub, Omar
    Rybak, Eva
    Reardon, David P.
    Krause, Patricia
    Connors, Jean M.
    JOURNAL OF EMERGENCY MEDICINE, 2016, 50 (01) : 7 - 13
  • [45] Global coagulation tests: their applicability for measuring direct factor Xa- and thrombin inhibition and reversal of anticoagulation by prothrombin complex concentrate
    Dinkelaar, Jasper
    Patiwael, Sanne
    Harenberg, Job
    Leyte, Anja
    Brinkman, Herm Jan M.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2014, 52 (11) : 1615 - 1623
  • [46] Activated prothrombin complex concentrate to reverse the factor Xa inhibitor (apixaban) effect before emergency surgery: A case series
    Schultz N.H.
    Lundblad R.
    Holme P.A.
    Journal of Medical Case Reports, 12 (1)
  • [47] Quality evaluation of case series describing four-factor prothrombin complex concentrate in oral factor Xa inhibitor-associated bleeding: a systematic review
    Costa, Olivia S.
    Baker, William L.
    Roman-Morillo, Yuani
    McNeil-Posey, Kelly
    Lovelace, Belinda
    White, C. Michael
    Coleman, Craig, I
    BMJ OPEN, 2020, 10 (11):
  • [48] Activated prothrombin complex concentrate for warfarin reversal in traumatic intracranial hemorrhage
    Carothers, Chancey
    Giancarelli, Amanda
    Ibrahim, Joseph
    Hobbs, Brandon
    JOURNAL OF SURGICAL RESEARCH, 2018, 223 : 183 - 187
  • [49] The impact of a three-factor prothrombin complex concentrate on the anticoagulatory effects of the factor Xa inhibitor edoxaban
    Brown, Karen S.
    Wickremasingha, Prachi
    Parasrampuria, Dolly A.
    Weiss, Daniel
    Kochan, Jarema
    Dishy, Victor
    He, Ling
    Shi, Minggao
    THROMBOSIS RESEARCH, 2015, 136 (04) : 825 - 831
  • [50] Co-administration of Four-Factor Prothrombin Complex Concentrate With Andexanet alfa for Reversal of Nontraumatic Intracranial Hemorrhage
    Pathan, Sophia
    HOSPITAL PHARMACY, 2024, 59 (04) : 394 - 406
12345